The Lancet Diabetes and Endocrinology

SJR Rank #69H-index: 207SJR: 11.610Best quartile: Q1APC: US$7,280
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

20222025036912

Subject Categories

  • EndocrinologyQ1
  • Endocrinology, Diabetes and MetabolismQ1
  • Internal MedicineQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes and associated disordersDiabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetesDiet and metabolism studiesBariatric Surgery and OutcomesMetabolism, Diabetes, and CancerDiabetes Management and EducationGlobal Public Health Policies and Epidemiology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025050100150200

Detailed Information

ISSN

2213-8595, 2213-8587

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

9.10

References per Document

20.91

Coverage

2013-2026

Scope

Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.

Metrics from SCImago Journal Rank 2025. View on SCImago